Abstract
Chromatin remodeling is a fundamental phenomenon in the life of eukaryotic cells, bearing implications to numerous physiological and pathological phenomena. This review outlines the chemistry of natural and synthetic agents endowed with the ability to interfere with such biological function, with a particular emphasis on histone deacetylase (HDAC) inhibitors. Other aspects covered in this article comprise structure activity relationships (SAR) and modes of action at molecular level, including the description of crystal structures of enzyme-inhibitor complexes.
Keywords: Epigenetic therapy, Histone deacetylase, Histone acetyltransferase, HDAC inhibitors, Antitumor, Apoptosis, Chromatin remodeling agents
Current Medicinal Chemistry
Title: Chemistry and Biology of Chromatin Remodeling Agents: State of Art and Future Perspectives of HDAC Inhibitors
Volume: 13 Issue: 10
Author(s): Manuela Rodriquez, Maurizio Aquino, Ines Bruno, Giovanni De Martino, Maurizio Taddei and Luigi Gomez-Paloma
Affiliation:
Keywords: Epigenetic therapy, Histone deacetylase, Histone acetyltransferase, HDAC inhibitors, Antitumor, Apoptosis, Chromatin remodeling agents
Abstract: Chromatin remodeling is a fundamental phenomenon in the life of eukaryotic cells, bearing implications to numerous physiological and pathological phenomena. This review outlines the chemistry of natural and synthetic agents endowed with the ability to interfere with such biological function, with a particular emphasis on histone deacetylase (HDAC) inhibitors. Other aspects covered in this article comprise structure activity relationships (SAR) and modes of action at molecular level, including the description of crystal structures of enzyme-inhibitor complexes.
Export Options
About this article
Cite this article as:
Rodriquez Manuela, Aquino Maurizio, Bruno Ines, Martino De Giovanni, Taddei Maurizio and Gomez-Paloma Luigi, Chemistry and Biology of Chromatin Remodeling Agents: State of Art and Future Perspectives of HDAC Inhibitors, Current Medicinal Chemistry 2006; 13 (10) . https://dx.doi.org/10.2174/092986706776360905
DOI https://dx.doi.org/10.2174/092986706776360905 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
Call for Papers in Thematic Issues
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.
The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more
Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications
The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more
Chalcogen-modified nucleic acid analogues
Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more
Current advances in inherited cardiomyopathy
Describe in detail all novel advances in multimodality imaging related to inherited cardiomyopathy diagnosis and prognosis. Shed light to deeper phenotypic characterization. Acknowledge recent advances in genetics, genomics and precision medicineread more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
New Approaches for the Treatment of Chagas Disease
Current Drug Targets Pharmacological Management of Acutely Agitated Schizophrenic Patients
Current Pharmaceutical Design Whether Early Steroid dose is Associated with Lower Mortality in COVID-19 Critically Ill Patients-An Exploratory Chart Review
Recent Advances in Anti-Infective Drug Discovery Modified Hummel-Dreyer Method and Molecular Modeling Studies Identified Nicotinic Acid Analogues as Carbonic Anhydrase III Ligands
Letters in Drug Design & Discovery The Concept of Repurposing in COVID-19 Infection
Coronaviruses Charcot-Marie-Tooth Disease and Related Hereditary Neuropathies: From Gene Function to Associated Phenotypes
Current Molecular Medicine Patents in Targets and Drugs for Unbalanced Cytokine and Chemokine Network Mediated Disorders
Recent Patents on Inflammation & Allergy Drug Discovery Targeting the AKT Pathway in Glioblastoma
Current Pharmaceutical Design An Updated and Focused Review on Heterocyclic Inhibitors for SARSCoV and SARS-CoV-2 3CL<sup>pro</sup>
Mini-Reviews in Medicinal Chemistry Molecular Descriptors of Some Chemicals that Prevent COVID-19
Current Organic Synthesis Prediction of Metabolism of Drugs using Artificial Intelligence: How far have we reached?
Current Drug Metabolism Critical Insight into the Attributes of Emerging Novel Coronavirus (COVID-19) in India and Across the World
Coronaviruses The Role and Significance of Unconventional Hydrogen Bonds in Small Molecule Recognition by Biological Receptors of Pharmaceutical Relevance
Current Pharmaceutical Design Mining Sarcomas by Proteomics Approaches: Ewing Sarcoma on the Spotlight
Recent Patents on Biotechnology COVID-19, Angiotensin-Converting Enzyme 2 and Renin-Angiotensin System Inhibition: Implications for Practice
Current Hypertension Reviews Fetal Encephalomalacia Secondary to Acute Maternal Blood Loss: A Case Study
New Emirates Medical Journal CoMSIA/QSAR Models for Vacuolar (H+) ATPase Inhibition by Selected Benzoate and Benzolactone Species
Letters in Drug Design & Discovery Design, Synthesis and Biological Evaluation of Ligands Selective for the Melanocortin-3 Receptor
Current Topics in Medicinal Chemistry Recent Progress of Small Molecular VEGFR Inhibitors as Anticancer Agents
Mini-Reviews in Medicinal Chemistry Gene Polymorphism of Angiotensin II Type 1 and Type 2 Receptors
Current Pharmaceutical Design